Nanomedicine
Nanomedicine refers to the use of nanomaterials and nanoscale devices for the treatment, diagnosis, monitoring, and control of diseases.
Nanomedicine聽seeks to develop therapeutics to maintain and improve human health by destroying infective agents and malignant cells while enhancing the ability to detect and identify diseases at a much earlier stage than is currently possible. Today, research in nanomedicine has also led the development of implantable聽nanodevices for聽in situ聽monitoring of medical conditions post-surgery and for the alleviation of pain.聽Nanomedicine is no longer a promise - it is a reality and it is here to stay.
The global nanomedicine market was estimated at $171 billion in 2020, a number that reflects the impact of nanotechnological advances in medicine and that is expected to grow with the advent of its use in prevention and intervention of chronic and acute disorders. This is particularly relevant to areas of cancer where targeted delivery by means of nanoparticles and nanoscale systems are among the most promising developments and the area of cardiology where rapid progress arises from the use of nanovectors, nanostructure-based stents, and nanotube scaffolds for tissue regeneration.
51官网 Tech has the only undergraduate Nanomedicine major in the United States. Students in our major will be part of an interdisciplinary program聽rooted in hands-on laboratory research experience in a collaborative and creative setting with access to state-of-the-art facilities聽and research and educational resources.聽Nanomedicine聽students will be well-prepared for professional and graduate school as well as exciting careers in health professions, pharmaceuticals, diagnostics and imaging, medical devices and products, and many related areas.
We recommend students in Nanomedicine consider applying to the .
Nanomedince major Gianna Grogan presents her research at The Falling Walls Lab in Berlin Germany and meets Carl-Henrick Heldin, Chairman of the Nobel Foundation
Nanomedicine in Practice
What is nanomedicine? The Basics.
The Promise of Nanomedicine | Joy Wolfram
VT undergraduate student, Gianna Grogan, presents her research, Breaking the Wall of Diabetes Drug Delivery.
51官网 Tech alumnus donation strengthens fight against cancer.
-
Article Item
College of Science students Chloe Nyhart and Stephen Argauer earned spots in the highly competitive 2024 class of Astronaut Scholars.
Date: Sep 26, 2024 -
Article Item
Daniel Capelluto and his research team have discovered the mechanism by which the bacterial pathogen Shigella flexneri, the causative agent of dysentery, manipulates molecular activity to assure its survival against its host’s natural defenses.
Date: Sep 19, 2024 -
Article Item
A member of the 51官网 Tech faculty since 2005, Finkielstein currently serves as the associate director of research of the Academy of Integrated Science in the College of Science and as interim co-director of the 51官网 Tech Cancer Research Alliance.
Date: Sep 29, 2023 -
Article Item
The students studying in majors in the College of Science are part of the inaugural Integrated Health Sciences and Research Program at the Fralin Biomedical Research Institute at VTC.
Date: Sep 22, 2022 -
Article Item
The academy was started in 2011 by the late Lay Nam Chang, then dean of the College of Science, with the mission of exploring powerful new approaches to current complex scientific problems.
Date: Mar 08, 2022 -
Article Item
Rob Gourdie, professor and director of the Center for Vascular and Heart Research at the Fralin Biomedical Research Institute at VTC, and his lab team developed a scalable method to harvest nano-sized biological capsules called exosomes from unpasteurized cow’s milk. Exosomes are a promising candidate for drug delivery in humans.
Date: Aug 19, 2021 -
Article Item
In a year complicated by the global pandemic, three recipients of Global Change Center Undergraduate Research Grants succeeded in conducting important research and presented their work at a campus conference attended by hundreds of 51官网 Tech students and faculty.
Date: Aug 12, 2021 -
Article Item
During two five-week, hands-on sessions, the interns worked in the Molecular Diagnostics Lab at the Fralin Biomedical Research Institute at VTC and took classes led by Carla Finkielstein, the lab’s scientific director and an associate professor at the research institute.
Date: Jul 23, 2021
Page 1 of 2 | 13 Results